文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

缓慢释放硫化氢分子GYY4137在已有冠状动脉疾病的猪复苏脓毒性休克中的代谢、心脏和肾脏效应

Metabolic, Cardiac, and Renal Effects of the Slow Hydrogen Sulfide-Releasing Molecule GYY4137 During Resuscitated Septic Shock in Swine with Pre-Existing Coronary Artery Disease.
PubMed 文献 · Shock · 2017-01-01
一句话结论在已有冠状动脉疾病的猪复苏脓毒性休克模型中,GYY4137使代谢转向优先利用碳水化合物,增加有氧葡萄糖氧化和外源性葡萄糖需求,并降低动脉pH和碱剩余,可能因局部NO可利用性降低而升高肌钙蛋白;对心脏、肾脏功能和全身炎症反应无显著影响。

研究在遗传和饮食诱导的冠状动脉疾病(CAD)猪中,用粪腹膜炎诱导复苏脓毒性休克,于腹膜炎诱导后12和18小时给予GYY4137(10 mg/kg,n=9)或溶媒(n=8)。在脓毒症前、12和24小时评估左心室功能(压力-电导导管)、肾脏功能(肌酐清除率、血NGAL水平),并通过血浆葡萄糖同位素和连续静脉输注1,2,3,4,5,6-C6-葡萄糖期间呼气CO2/CO2富集推导内源性葡萄糖生成和葡萄糖氧化。GYY4137显著增加有氧葡萄糖氧化,同时维持血糖正常所需外源性葡萄糖增加,动脉pH显著降低、碱剩余减少;除心脏eNOS表达显著降低和肌钙蛋白水平升高外,GYY4137未显著影响心脏和肾脏功能或全身炎症反应。作者认为,GYY4137使代谢转向优先利用碳水化合物,肌钙蛋白升高可能因局部NO可利用性降低,谨慎给药、给药时机和种属差异可能解释此前描述的GYY4137抗炎或器官保护效应在本模型中缺失。

要点

  • 在已有CAD的猪复苏脓毒性休克中,GYY4137(10 mg/kg,腹膜炎诱导后12和18小时给药)显著增加有氧葡萄糖氧化。
  • GYY4137组维持血糖正常所需外源性葡萄糖增加,同时动脉pH显著降低、碱剩余减少。
  • GYY4137组心脏eNOS表达显著降低、肌钙蛋白水平升高,但心脏和肾脏功能无显著影响。
  • GYY4137未显著影响全身炎症反应,此前描述的GYY4137抗炎或器官保护效应在本模型中缺失。
  • 作者认为,肌钙蛋白升高可能因局部NO可利用性降低,谨慎给药、给药时机和种属差异可能解释效应缺失。

适用人群与场景

  • 遗传和饮食诱导的冠状动脉疾病(CAD)猪,经粪腹膜炎诱导复苏脓毒性休克。

处置流程与药物剂量

  • 于腹膜炎诱导后12和18小时给予GYY4137(10 mg/kg)或溶媒。
  • 持续静脉输注1,2,3,4,5,6-C6-葡萄糖,用于推导内源性葡萄糖生成和葡萄糖氧化。

研究设计与关键结果

  • 研究类型为动物实验(猪),GYY4137组n=9,溶媒组n=8。
  • GYY4137显著增加有氧葡萄糖氧化,并增加维持血糖正常所需外源性葡萄糖。
  • GYY4137组动脉pH显著降低、碱剩余减少。
  • GYY4137组心脏eNOS表达显著降低、肌钙蛋白水平升高。
  • GYY4137未显著影响心脏和肾脏功能或全身炎症反应。

证据类型、等级与局限

  • 证据类型:动物实验(猪)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,GYY4137使代谢转向优先利用碳水化合物,肌钙蛋白升高可能因局部NO可利用性降低。
  • 作者认为,谨慎给药、给药时机和种属差异可能解释此前描述的GYY4137抗炎或器官保护效应在本模型中缺失。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Decreased levels of endogenous hydrogen sulfide (H2S) contribute to atherosclerosis, whereas equivocal data are available on H2S effects during sepsis. Moreover, H2S improved glucose utilization in anaesthetized, ventilated, hypothermic mice, but normothermia and/or sepsis blunted this effect. The metabolic effects of H2S in large animals are controversial. Therefore, we investigated the effects of the H2S donor GYY4137 during resuscitated, fecal peritonitis-induced septic shock in swine with genetically and diet-induced coronary artery disease (CAD). Twelve and 18 h after peritonitis induction, pigs received either GYY4137 (10 mg kg, n = 9) or vehicle (n = 8). Before, at 12 and 24 h of sepsis, we assessed left ventricular (pressure-conductance catheters) and renal (creatinine clearance, blood NGAL levels) function. Endogenous glucose production and glucose oxidation were derived from the plasma glucose isotope and the expiratory CO2/CO2 enrichment during continuous i.v. 1,2,3,4,5,6-C6-glucose infusion. GYY4137 significantly increased aerobic glucose oxidation, which coincided with higher requirements of exogenous glucose to maintain normoglycemia, as well as significantly lower arterial pH and decreased base excess. Apart from significantly lower cardiac eNOS expression and higher troponin levels, GYY4137 did not significantly influence cardiac and kidney function or the systemic inflammatory response. During resuscitated septic shock in swine with CAD, GYY4137 shifted metabolism to preferential carbohydrate utilization. Increased troponin levels are possibly due to reduced local NO availability. Cautious dosing, the timing of GYY4137 administration, and interspecies differences most likely account for the absence of any previously described anti-inflammatory or organ-protective effects of GYY4137 in this model.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Nußbaum BL, Vogt J, Wachter U, et al. Metabolic, Cardiac, and Renal Effects of the Slow Hydrogen Sulfide-Releasing Molecule GYY4137 During Resuscitated Septic Shock in Swine with Pre-Existing Coronary Artery Disease. Shock. 2017. PMID: 28107215. doi:10.1097/SHK.0000000000000834

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。